Biomolecule-functionalized nanoformulations for prostate cancer theranostics.

ABSTRACT:

Background

Even with the advancement in the areas of cancer nanotechnology, prostate cancer still poses a major threat to men's health. Nanomaterials and nanomaterial-derived theranostic systems have been explored for diagnosis, imaging, and therapy for different types of cancer still, for prostate cancer they have not delivered at full potential because of the limitations like in vivo biocompatibility, immune responses, precise targetability, and therapeutic outcome associated with the nanostructured system.

Aim of review

Functionalizing nanomaterials with different biomolecules and bioactive agents provides advantages like specificity towards cancerous tumors, improved circulation time, and modulation of the immune response leading to early diagnosis and targeted delivery

SUBMITTER: Pranav 

PROVIDER: S-EPMC10491979 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature